Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George H Talbot

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 19, 2019
Erratum to: Efficacy and Safety of Intravenous-to-oral Lefamulin, a Pleuromutilin Antibiotic, for the Treatment of Community-acquired Bacterial Pneumonia: The Phase III Lefamulin Evaluation Against Pneumonia (LEAP 1) TrialThomas M File, Lisa Goldberg, Anita Das, et al.
The New England Journal of Medicine|February 21, 2019
Plazomicin for Infections Caused by Carbapenem-Resistant EnterobacteriaceaeJames A McKinnell, Jamie P Dwyer, George H Talbot, et al.
Journal of Chemotherapy (Florence, Italy)|November 7, 2002
Clinical and public health implications of macrolide-resistant Streptococcus pneumoniaeR C Moellering, William Craig, Michael Edmond, et al.
The Journal of Infectious Diseases|January 17, 2019
Evidence-Based Study Design for Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial PneumoniaGeorge H Talbot, Anita Das, Stephanie Cush, et al.
The Lancet. Infectious Diseases|February 3, 2019
Cadazolid for the treatment of Clostridium difficile infection: results of two double-blind, placebo-controlled, non-inferiority, randomised phase 3 trialsDale N Gerding, Oliver A Cornely, Simon Grill, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 6, 2019
Elaboration of Consensus Clinical Endpoints to Evaluate Antimicrobial Treatment Efficacy in Future Hospital-acquired/Ventilator-associated Bacterial Pneumonia Clinical TrialsEmmanuel Weiss, Jean-Ralph Zahar, Jeff Alder, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 19, 2019
Erratum to: Efficacy and Safety of Intravenous-to-oral Lefamulin, a Pleuromutilin Antibiotic, for the Treatment of Community-acquired Bacterial Pneumonia: The Phase III Lefamulin Evaluation Against Pneumonia (LEAP 1) TrialThomas M File, Lisa Goldberg, Anita Das, et al.
The New England Journal of Medicine|February 21, 2019
Plazomicin for Infections Caused by Carbapenem-Resistant EnterobacteriaceaeJames A McKinnell, Jamie P Dwyer, George H Talbot, et al.
Journal of Chemotherapy (Florence, Italy)|November 7, 2002
Clinical and public health implications of macrolide-resistant Streptococcus pneumoniaeR C Moellering, William Craig, Michael Edmond, et al.
The Journal of Infectious Diseases|January 17, 2019
Evidence-Based Study Design for Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial PneumoniaGeorge H Talbot, Anita Das, Stephanie Cush, et al.
The Lancet. Infectious Diseases|February 3, 2019
Cadazolid for the treatment of Clostridium difficile infection: results of two double-blind, placebo-controlled, non-inferiority, randomised phase 3 trialsDale N Gerding, Oliver A Cornely, Simon Grill, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 6, 2019
Elaboration of Consensus Clinical Endpoints to Evaluate Antimicrobial Treatment Efficacy in Future Hospital-acquired/Ventilator-associated Bacterial Pneumonia Clinical TrialsEmmanuel Weiss, Jean-Ralph Zahar, Jeff Alder, et al.
Pageof 5